🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In cystic fibrosis, there is a critical need for better predictors of treat...
Status
Completed
Location
National Jewish Health
Start Date
2012-11
Trial ID
NCT01736839
Determine the PK and safety and tolerability of aztreonam-avibactam (ATM-AV...
Status
Completed
Location
University Hospital C.
Start Date
2016-05-19
Trial ID
NCT02655419
Treatments Being Tested
The purpose of this study was to evaluate the safety and efficacy of a 28-d...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2005-05
Trial ID
NCT00112359
Treatments Being Tested
Based on the current literature, investigators hypothesize that patients wi...
Status
Terminated
Location
University of Louisville
Start Date
2014-03-06
Trial ID
NCT02099240
Treatments Being Tested
This study is being conducted in men scheduled to undergo transrectal ultra...
Status
Completed
Location
Northwestern University Department of Urology
Start Date
2012-08
Trial ID
NCT01659866
This is a randomised, double-blind, 3-part study designed to investigate th...
Status
Completed
Location
Research Site
Start Date
2012-09
Trial ID
NCT01689207
Treatments Being Tested
The purpose of this study is to determine whether ceftaroline is effective ...
Status
Completed
Location
Investigational Site
Start Date
2007-02
Trial ID
NCT00424190
Treatments Being Tested
This is multicenter placebo-controlled study evaluating the safety and effi...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT01055847
Treatments Being Tested
This is a pilot study of inhaled antibiotic regimens is a pilot study exami...
Status
Completed
Location
Indiana University
Start Date
2011-03
Trial ID
NCT01319253
Phase 3 study to evaluate the efficacy and safety of cefepime/nacubactam or...
Status
Completed
Location
Meiji Research Site
Start Date
2023-05-23
Trial ID
NCT05887908